Garcoa Laboratories Inc – Trademark Portfolio
Entity Type: 03
Garcoa Laboratories Inc holds 43 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 37 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include PERUVIAN OIL, LOVE THAT BODY, and AGAVE AZUL SOOTHING SHAMPOO. The owner is based in Calabasas, CA.
www.garcoalaboratories.com
26135 Mureau Road
Calabasas, CA 91302
Showing of trademarks Trademarks
Trademark Classifications
Garcoa Laboratories Inc's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Garcoa Laboratories Inc have?
Garcoa Laboratories Inc has 43 U.S. trademarks filed with the USPTO. Of these, 3 registered, 16 abandoned, 24 cancelled.
What trademark classes does Garcoa Laboratories Inc file in?
Garcoa Laboratories Inc files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Garcoa Laboratories Inc's most well-known trademarks?
Garcoa Laboratories Inc's registered trademark portfolio includes well-known marks such as PERUVIAN OIL, LOVE THAT BODY, and AGAVE AZUL SOOTHING SHAMPOO. These are among 3 currently registered trademarks in the portfolio.
What is Garcoa Laboratories Inc's trademark registration success rate?
Garcoa Laboratories Inc has a 7% trademark registration rate, with 3 out of 43 resolved applications resulting in successful registration. Currently, 0 applications are pending review.